Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]
News [4946]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Optimum treatment strategy algorithm for mCRC
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Optimum treatment strategy algorithm for mCRC ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
15 Aug 2022
Bladder cancer: Current state and future directions in treatment
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case...
Bladder cancer: Current state and future directions in treatment ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022
Optimum treatment algorithm in management of advanced prostate cancer
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case...
Optimum treatment algorithm in management of advanced prostate cancer ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
15 Aug 2022
Topics under discussion at the WCLC 2022 presidential symposium
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Topics under discussion at the WCLC 2022 presidential symposium ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
9 Aug 2022
Atezolizumab vs best supportive care in resected NSCLC
Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Atezolizumab vs best supportive care in resected NSCLC ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
9 Aug 2022
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC
Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC ( Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA )
8 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022
Low-dose nivolumab leads to improved overall survival for head and neck cancer...
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022
Updates from the PROpel and MAGNITUDE studies
Prof Phil Cornford and Dr Elena Castro
Updates from the PROpel and MAGNITUDE studies ( Prof Phil Cornford and Dr Elena Castro )
11 Jul 2022
Current EAU guidelines on treating prostate cancer
Prof Eleni Efstathiou and Prof Nicolas Mottet
Current EAU guidelines on treating prostate cancer ( Prof Eleni Efstathiou and Prof Nicolas Mottet )
11 Jul 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation